Olaparib, a drug that targets cancer cells with faulty genetic code, is on track to become the first-ever precision medicine for prostate cancer.
Friday, 4th October 2019
This is certainly worth a read - click here to view. It may have my name at the top (Dave) but just ignore it.
July 2022 Support Group Meeting
12 Jul 2022 19:00–20:30
August 2022 Support Group Meeting
23 Aug 2022 19:00–20:30
October 2022 Support Group Meeting
4 Oct 2022 19:00–20:30
November 2022 Support Group Meeting
15 Nov 2022 19:00–20:30